← All trials
NCT04808362
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 28, 2021
- Primary completion
- Aug 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Mar 22, 2021
- Last posted
- May 7, 2021
- Enrollment
- 74
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peptomyc S.L.Lead sponsor
- Universidad Autonoma de BarcelonaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.